Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth K Lee

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Oncology (Williston Park, N.Y.)|November 29, 2017
Strategies for Addressing Cancer Patients' Complaints of FatigueCatherine B Saiki, Julie M Waldfogel, Elizabeth K Lee, et al.
Psychological Trauma : Theory, Research, Practice and Policy|May 4, 2023
Perceived severity of childhood emotional, sexual, and physical abuse: Comparisons across psychologists, students, and the general publicViann N Nguyen-Feng, Linda Zheng, Catherine M Reich, et al.
Gynecologic Oncology|July 18, 2025
The RAS-MEK-ERK pathway in low-grade serous ovarian cancerElizabeth H Stover, Elizabeth K Lee, Geoffrey I Shapiro, et al.
International Journal of Yoga Therapy|July 3, 2026
Integration of Dialectical Behavior Therapy and Trauma Center Trauma-Sensitive Yoga: Expert Opinion via Delphi MethodologyKelsey M Dietrich, Joseph G Davidson, Rachel Willhite, et al.
Gynecologic Oncology Reports|August 31, 2019
Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancerElizabeth K Lee, Zhenying Tan-Wasielewski, Ursula A Matulonis, et al.
Gynecologic Oncology Reports|July 18, 2025
Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcomaStephanie Cham, Niya Xiong, Nabihah Tayob, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 8, 2020
Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 casesDavid B Chapel, Elizabeth K Lee, Annacarolina F L Da Silva, et al.
Gynecologic Oncology Reports|February 22, 2020
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)Elizabeth K Lee, Zhenying Tan-Wasielewski, Carol Aghajanian, et al.
Gynecologic Oncology|April 3, 2019
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancerJennifer Taylor Veneris, Elizabeth K Lee, Emily A Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor CamonsertibEzra Rosen, Timothy A Yap, Elizabeth K Lee, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|November 29, 2017
Strategies for Addressing Cancer Patients' Complaints of FatigueCatherine B Saiki, Julie M Waldfogel, Elizabeth K Lee, et al.
Psychological Trauma : Theory, Research, Practice and Policy|May 4, 2023
Perceived severity of childhood emotional, sexual, and physical abuse: Comparisons across psychologists, students, and the general publicViann N Nguyen-Feng, Linda Zheng, Catherine M Reich, et al.
Gynecologic Oncology|July 18, 2025
The RAS-MEK-ERK pathway in low-grade serous ovarian cancerElizabeth H Stover, Elizabeth K Lee, Geoffrey I Shapiro, et al.
International Journal of Yoga Therapy|July 3, 2026
Integration of Dialectical Behavior Therapy and Trauma Center Trauma-Sensitive Yoga: Expert Opinion via Delphi MethodologyKelsey M Dietrich, Joseph G Davidson, Rachel Willhite, et al.
Gynecologic Oncology Reports|August 31, 2019
Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancerElizabeth K Lee, Zhenying Tan-Wasielewski, Ursula A Matulonis, et al.
Gynecologic Oncology Reports|July 18, 2025
Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcomaStephanie Cham, Niya Xiong, Nabihah Tayob, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 8, 2020
Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 casesDavid B Chapel, Elizabeth K Lee, Annacarolina F L Da Silva, et al.
Gynecologic Oncology Reports|February 22, 2020
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)Elizabeth K Lee, Zhenying Tan-Wasielewski, Carol Aghajanian, et al.
Gynecologic Oncology|April 3, 2019
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancerJennifer Taylor Veneris, Elizabeth K Lee, Emily A Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor CamonsertibEzra Rosen, Timothy A Yap, Elizabeth K Lee, et al.
Pageof 4